Acquired BTK mutations associated with resistance to noncovalent BTK inhibitors
| Errataetall: |
CommentOn: N Engl J Med. 2022 Feb 24;386(8):735-743. - PMID 35196427 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
Blood advances - 7(2023), 19 vom: 10. Okt., Seite 5698-5702 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Qi, Jialei [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 06.11.2023 Date Revised 06.11.2023 published: Print CommentOn: N Engl J Med. 2022 Feb 24;386(8):735-743. - PMID 35196427 Citation Status MEDLINE |
|---|
| doi: |
10.1182/bloodadvances.2022008955 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM35172074X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM35172074X | ||
| 003 | DE-627 | ||
| 005 | 20231226052045.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/bloodadvances.2022008955 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1172.xml |
| 035 | |a (DE-627)NLM35172074X | ||
| 035 | |a (NLM)36661329 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Qi, Jialei |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Acquired BTK mutations associated with resistance to noncovalent BTK inhibitors |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.11.2023 | ||
| 500 | |a Date Revised 06.11.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: N Engl J Med. 2022 Feb 24;386(8):735-743. - PMID 35196427 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Agammaglobulinaemia Tyrosine Kinase |2 NLM | |
| 650 | 7 | |a EC 2.7.10.2 |2 NLM | |
| 700 | 1 | |a Endres, Sascha |e verfasserin |4 aut | |
| 700 | 1 | |a Yosifov, Deyan Yordanov |e verfasserin |4 aut | |
| 700 | 1 | |a Tausch, Eugen |e verfasserin |4 aut | |
| 700 | 1 | |a Dheenadayalan, Rashmi Priyadharshini |e verfasserin |4 aut | |
| 700 | 1 | |a Gao, Xiang |e verfasserin |4 aut | |
| 700 | 1 | |a Müller, Annika |e verfasserin |4 aut | |
| 700 | 1 | |a Schneider, Christof |e verfasserin |4 aut | |
| 700 | 1 | |a Mertens, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Gierschik, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Wist, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Jebaraj, Billy Michael Chelliah |e verfasserin |4 aut | |
| 700 | 1 | |a Stilgenbauer, Stephan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood advances |d 2016 |g 7(2023), 19 vom: 10. Okt., Seite 5698-5702 |w (DE-627)NLM268683263 |x 2473-9537 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2023 |g number:19 |g day:10 |g month:10 |g pages:5698-5702 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1182/bloodadvances.2022008955 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2023 |e 19 |b 10 |c 10 |h 5698-5702 | ||